Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-cash Items: 2021-2024

Historic Non-cash Items for Organogenesis Holdings (ORGO) over the last 4 years, with Dec 2024 value amounting to $2.5 million.

  • Organogenesis Holdings' Non-cash Items rose 89.83% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 89.83%. This contributed to the annual value of $2.5 million for FY2024, which is 75.45% down from last year.
  • Per Organogenesis Holdings' latest filing, its Non-cash Items stood at $2.5 million for FY2024, which was down 75.45% from $10.3 million recorded in FY2023.
  • Organogenesis Holdings' Non-cash Items' 5-year high stood at $38.5 million during FY2021, with a 5-year trough of $2.5 million in FY2024.
  • In the last 3 years, Organogenesis Holdings' Non-cash Items had a median value of $3.1 million in 2022 and averaged $5.3 million.
  • In the last 5 years, Organogenesis Holdings' Non-cash Items plummeted by 92.01% in 2022 and then soared by 233.44% in 2023.
  • Organogenesis Holdings' Non-cash Items (Yearly) stood at $38.5 million in 2021, then tumbled by 92.01% to $3.1 million in 2022, then surged by 233.44% to $10.3 million in 2023, then plummeted by 75.45% to $2.5 million in 2024.